Breaking News Instant updates and real-time market news.

ERRFY

Eurofins Scientific

$0.00 /

+ (+0.00%)

15:40
03/02/21
03/02
15:40
03/02/21
15:40

Eurofins Scientific price target raised to EUR 77 from EUR 75 at Morgan Stanley

Morgan Stanley analyst Edward Stanley raised the firm's price target on Eurofins Scientific to EUR 77 from EUR 75 and keeps an Equal Weight rating on the shares.

ERRFY Eurofins Scientific
$0.00 /

+ (+0.00%)

03/02/21 Deutsche Bank
Eurofins Scientific price target raised to EUR 57 from EUR 55 at Deutsche Bank
02/11/21 Barclays
Eurofins Scientific price target raised to EUR 90 from EUR 80 at Barclays
02/11/21 Morgan Stanley
Eurofins Scientific upgraded to Equal Weight from Underweight at Morgan Stanley
01/27/21 Berenberg
Eurofins Scientific price target raised to EUR 88 from EUR 83.50 at Berenberg

TODAY'S FREE FLY STORIES

Upgrade
Veolia Environment upgraded to Overweight from Equal Weight at Barclays » 06:27
04/23/21
04/23
06:27
04/23/21
06:27
VEOEY

Veolia Environment

$30.12 /

+0.414 (+1.39%)

Barclays analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VEOEY Veolia Environment
$30.12 /

+0.414 (+1.39%)

VEOEY Veolia Environment
$30.12 /

+0.414 (+1.39%)

04/13/21 Bryan Garnier
Veolia Environment downgraded to Neutral from Buy at Bryan Garnier
03/08/21 Barclays
Veolia Environment price target raised to EUR 24 from EUR 22.50 at Barclays
02/26/21 DZ Bank
Veolia Environment upgraded to Buy from Hold at DZ Bank
02/16/21 Berenberg
Veolia Environment price target raised to EUR 30 from EUR 21 at Berenberg
Upgrade
Verbund upgraded to Hold from Sell at Societe Generale » 06:27
04/23/21
04/23
06:27
04/23/21
06:27
OEZVY

Verbund

$16.00 /

-0.725 (-4.34%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OEZVY Verbund
$16.00 /

-0.725 (-4.34%)

05:12 Today Societe Generale
Verbund upgraded to Hold from Sell at Societe Generale
03/18/21 Barclays
Verbund price target lowered to EUR 55 from EUR 56 at Barclays
03/18/21 Oddo BHF
Verbund downgraded to Underperform from Neutral at Oddo BHF
03/10/21 Credit Suisse
Verbund price target raised to EUR 46.50 from EUR 43.50 at Credit Suisse
Downgrade
CaixaBank downgraded to Neutral from Outperform at Credit Suisse » 06:26
04/23/21
04/23
06:26
04/23/21
06:26
CAIXY

CaixaBank

$1.01 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAIXY CaixaBank
$1.01 /

+ (+0.00%)

04/07/21 Morgan Stanley
CaixaBank resumed with an Overweight at Morgan Stanley
04/06/21 Barclays
CaixaBank price target raised to EUR 3 from EUR 2.70 at Barclays
03/26/21 JPMorgan
CaixaBank price target raised to EUR 2.80 from EUR 2.65 at JPMorgan
03/05/21 Berenberg
CaixaBank price target raised to EUR 2.45 from EUR 1.85 at Berenberg
Downgrade
EVN AG downgraded to Equal Weight from Overweight at Barclays » 06:26
04/23/21
04/23
06:26
04/23/21
06:26
EVNVY

EVN AG

$4.30 /

+ (+0.00%)

Barclays analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVNVY EVN AG
$4.30 /

+ (+0.00%)

12/18/20 Barclays
EVN AG upgraded to Overweight from Equal Weight at Barclays
12/17/20 Kepler Cheuvreux
EVN AG upgraded to Buy from Hold at Kepler Cheuvreux
Conference/Events
UBS chief economists to hold an analyst/industry conference call » 06:25
04/23/21
04/23
06:25
04/23/21
06:25

Chief Economists Kapteyn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
G1 Therapeutics transferred with Outperform at Cowen » 06:24
04/23/21
04/23
06:24
04/23/21
06:24
GTHX

G1 Therapeutics

$22.69 /

+0.16 (+0.71%)

Cowen analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTHX G1 Therapeutics
$22.69 /

+0.16 (+0.71%)

GTHX G1 Therapeutics
$22.69 /

+0.16 (+0.71%)

11/17/20 Raymond James
Raymond James downgrades G1 Therapeutics after removing rintodestrant from model
11/17/20 Raymond James
G1 Therapeutics downgraded to Outperform from Strong Buy at Raymond James
07/01/20 Wedbush
G1 Therapeutics price target lowered to $50 from $55 at Wedbush
06/26/20 Roth Capital
G1 Therapeutics initiated with a Buy at Roth Capital
GTHX G1 Therapeutics
$22.69 /

+0.16 (+0.71%)

Syndicate
EDAP TMS 4.15M share Spot Secondary priced at $6.75 » 06:23
04/23/21
04/23
06:23
04/23/21
06:23
EDAP

EDAP TMS

$8.40 /

-0.05 (-0.59%)

Piper Sandler acted as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDAP EDAP TMS
$8.40 /

-0.05 (-0.59%)

EDAP EDAP TMS
$8.40 /

-0.05 (-0.59%)

04/01/21 H.C. Wainwright
EDAP TMS price target raised to $12 from $10 at H.C. Wainwright
01/25/21 Lake Street
EDAP TMS initiated with a Buy at Lake Street
01/22/21 B. Riley Securities
EDAP TMS price target raised to $13 from $11.50 at B. Riley Securities
01/12/21 B. Riley Securities
EDAP TMS price target raised to $11.50 from $5.50 at B. Riley Securities
EDAP EDAP TMS
$8.40 /

-0.05 (-0.59%)

  • 23
    Apr
EDAP EDAP TMS
$8.40 /

-0.05 (-0.59%)

Recommendations
Y-mAbs Therapeutics transferred with Outperform at Cowen » 06:23
04/23/21
04/23
06:23
04/23/21
06:23
YMAB

Y-mAbs Therapeutics

$27.03 /

+0.3 (+1.12%)

Cowen analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

04/21/21 Wedbush
Y-mAbs Therapeutics price target lowered to $52 from $67 at Wedbush
03/22/21 JPMorgan
Y-mAbs Therapeutics assumed with an Overweight at JPMorgan
03/01/21 H.C. Wainwright
Y-mAbs Therapeutics price target raised to $70 from $65 at H.C. Wainwright
01/15/21 BofA
BofA cuts Y-mAbs Therapeutics to Neutral with near-term catalysts played out
YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

  • 18
    Feb
YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

YMAB Y-mAbs Therapeutics
$27.03 /

+0.3 (+1.12%)

Upgrade
SEB SA upgraded to Buy from Hold at Societe Generale » 06:23
04/23/21
04/23
06:23
04/23/21
06:23
SEBYF

SEB SA

$171.25 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEBYF SEB SA
$171.25 /

+ (+0.00%)

05:11 Today Societe Generale
SEB SA upgraded to Buy from Hold at Societe Generale
03/31/21 UBS
SEB SA price target raised to SEK 100 from SEK 91 at UBS
03/10/21 Societe Generale
SEB SA price target lowered to EUR 144 from EUR 158 at Societe Generale
03/08/21 Morgan Stanley
SEB SA price target raised to SEK 100 from SEK 92 at Morgan Stanley
Recommendations
Epizyme transferred with Outperform at Cowen » 06:21
04/23/21
04/23
06:21
04/23/21
06:21
EPZM

Epizyme

$7.88 /

-0.005 (-0.06%)

Cowen analyst Joe Thome…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPZM Epizyme
$7.88 /

-0.005 (-0.06%)

EPZM Epizyme
$7.88 /

-0.005 (-0.06%)

03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
02/25/21 Morgan Stanley
Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley
02/25/21 Morgan Stanley
Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley
EPZM Epizyme
$7.88 /

-0.005 (-0.06%)

EPZM Epizyme
$7.88 /

-0.005 (-0.06%)

Upgrade
Chimerix assumed with Outperform from Market Perform at Cowen » 06:20
04/23/21
04/23
06:20
04/23/21
06:20
CMRX

Chimerix

$8.21 /

-0.05 (-0.61%)

Cowen analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMRX Chimerix
$8.21 /

-0.05 (-0.61%)

CMRX Chimerix
$8.21 /

-0.05 (-0.61%)

03/31/21 Jefferies
Jefferies starts Chimerix at Buy with $21 price target
03/31/21 Wedbush
Wedbush bullish on Chimerix, initiates with an Outperform
03/31/21 Jefferies
Chimerix initiated with a Buy at Jefferies
03/31/21 Wedbush
Chimerix initiated with an Outperform at Wedbush
CMRX Chimerix
$8.21 /

-0.05 (-0.61%)

  • 21
    Jan
CMRX Chimerix
$8.21 /

-0.05 (-0.61%)

Initiation
Argenx initiated with a Neutral at Redburn » 06:20
04/23/21
04/23
06:20
04/23/21
06:20
ARGX

Argenx

$295.26 /

+5.52 (+1.91%)

Redburn analyst Charles…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARGX Argenx
$295.26 /

+5.52 (+1.91%)

ARGX Argenx
$295.26 /

+5.52 (+1.91%)

03/05/21 H.C. Wainwright
Argenx price target raised to $320 from $265 at H.C. Wainwright
02/18/21 Cowen
Argenx price target raised to $430 from $317 at Cowen
02/10/21 Barclays
Argenx price target raised to EUR 295 from EUR 215 at Barclays
02/04/21 Piper Sandler
Argenx price target raised to $309 from $303 at Piper Sandler
  • 03
    Feb
  • 28
    May
ARGX Argenx
$295.26 /

+5.52 (+1.91%)

Initiation
Adicet Bio initiated with a Buy at H.C. Wainwright » 06:18
04/23/21
04/23
06:18
04/23/21
06:18
ACET

Adicet Bio

$13.18 /

+0.38 (+2.97%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACET Adicet Bio
$13.18 /

+0.38 (+2.97%)

ACET Adicet Bio
$13.18 /

+0.38 (+2.97%)

04/14/21 Canaccord
Canaccord starts Adicet at Buy on 'highly favorable' CAR-T prospects
04/14/21 Canaccord
Adicet Bio initiated with a Buy at Canaccord
04/08/21 Guggenheim
Adicet Bio initiated with a Buy at Guggenheim
11/04/20
Fly Intel: Top five analyst initiations
  • 10
    Feb
  • 24
    Sep
ACET Adicet Bio
$13.18 /

+0.38 (+2.97%)

Periodicals
Two U.S. senators raise concerns over Tesla's autopilot, WSJ reports » 06:17
04/23/21
04/23
06:17
04/23/21
06:17
TSLA

Tesla

$719.79 /

-24.37 (-3.27%)

Two U.S. senators have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$719.79 /

-24.37 (-3.27%)

TSLA Tesla
$719.79 /

-24.37 (-3.27%)

04/22/21 Morgan Stanley
Tesla price target raised to $900 from $880 at Morgan Stanley
04/22/21 Citi
Citi keeps Sell rating, $159 target on Tesla into Q1 results
04/20/21 Mizuho
Tesla price target raised to $820 from $775 at Mizuho
04/13/21 Credit Suisse
Credit Suisse ahead of consensus into Q1 EPS for Tesla
TSLA Tesla
$719.79 /

-24.37 (-3.27%)

TSLA Tesla
$719.79 /

-24.37 (-3.27%)

TSLA Tesla
$719.79 /

-24.37 (-3.27%)

TSLA Tesla
$719.79 /

-24.37 (-3.27%)

Upgrade
Laurentian Bank upgraded to Sector Perform from Underperform at National Bank » 06:16
04/23/21
04/23
06:16
04/23/21
06:16
LRCDF

Laurentian Bank

$34.11 /

+2.06 (+6.43%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRCDF Laurentian Bank
$34.11 /

+2.06 (+6.43%)

LRCDF Laurentian Bank
$34.11 /

+2.06 (+6.43%)

04/22/21 RBC Capital
Laurentian Bank upgraded to Outperform from Sector Perform at RBC Capital
04/22/21 RBC Capital
Laurentian Bank upgraded to Outperform from Sector Perform at RBC Capital
03/05/21 Desjardins
Laurentian Bank price target raised to C$41 from C$33 at Desjardins
03/04/21 Credit Suisse
Laurentian Bank price target raised to C$36 from C$30 at Credit Suisse
Earnings
Autoliv reports Q1 adjusted EPS $1.79, consensus $1.42 » 06:16
04/23/21
04/23
06:16
04/23/21
06:16
ALV

Autoliv

$98.25 /

+0.67 (+0.69%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALV Autoliv
$98.25 /

+0.67 (+0.69%)

ALV Autoliv
$98.25 /

+0.67 (+0.69%)

04/15/21 Berenberg
Autoliv initiated with a Hold at Berenberg
03/25/21 Wells Fargo
Autoliv initiated with an Equal Weight at Wells Fargo
03/22/21 Nordea
Autoliv downgraded to Hold from Buy at Nordea
02/02/21 Citi
Autoliv price target raised to $97 from $94 at Citi
ALV Autoliv
$98.25 /

+0.67 (+0.69%)

ALV Autoliv
$98.25 /

+0.67 (+0.69%)

Periodicals
Apple's new iPad Pros to boost Foxconn's April revenues, DigiTimes reports » 06:14
04/23/21
04/23
06:14
04/23/21
06:14
HNHPF

Hon Hai Precision

$8.28 /

-0.3315 (-3.85%)

, AAPL

Apple

$131.96 /

-1.53 (-1.15%)

Apple's (AAPL) newly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HNHPF Hon Hai Precision
$8.28 /

-0.3315 (-3.85%)

AAPL Apple
$131.96 /

-1.53 (-1.15%)

HNHPF Hon Hai Precision
$8.28 /

-0.3315 (-3.85%)

AAPL Apple
$131.96 /

-1.53 (-1.15%)

04/21/21 Morgan Stanley
Apple shares 'on path to re-rate,' says Morgan Stanley
04/21/21 Canaccord
Apple refreshed product line supports positive thesis, says Canaccord
04/21/21 Bernstein
Apple event broader in scope than anticipated, says Bernstein
04/21/21 Atlantic Equities
Apple making push to fight Spotify for podcast creators, says Atlantic Equities
AAPL Apple
$131.96 /

-1.53 (-1.15%)

HNHPF Hon Hai Precision
$8.28 /

-0.3315 (-3.85%)

AAPL Apple
$131.96 /

-1.53 (-1.15%)

HNHPF Hon Hai Precision
$8.28 /

-0.3315 (-3.85%)

AAPL Apple
$131.96 /

-1.53 (-1.15%)

AAPL Apple
$131.96 /

-1.53 (-1.15%)

Downgrade
Cabot Oil & Gas downgraded to Peer Perform from Outperform at Wolfe Research » 06:14
04/23/21
04/23
06:14
04/23/21
06:14
COG

Cabot Oil & Gas

$16.37 /

-0.04 (-0.24%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COG Cabot Oil & Gas
$16.37 /

-0.04 (-0.24%)

COG Cabot Oil & Gas
$16.37 /

-0.04 (-0.24%)

04/20/21 Mizuho
Cabot Oil & Gas price target lowered to $21 from $23 at Mizuho
04/19/21 BMO Capital
Cabot Oil & Gas downgraded to Market Perform from Outperform at BMO Capital
03/23/21 Goldman Sachs
Cabot Oil & Gas assumed with a Neutral at Goldman Sachs
03/23/21 Citi
Cabot Oil & Gas price target lowered to $20.50 from $22 at Citi
COG Cabot Oil & Gas
$16.37 /

-0.04 (-0.24%)

COG Cabot Oil & Gas
$16.37 /

-0.04 (-0.24%)

Recommendations
D.R. Horton price target raised to $124 from $108 at BTIG » 06:13
04/23/21
04/23
06:13
04/23/21
06:13
DHI

D.R. Horton

$94.92 /

+1.74 (+1.87%)

BTIG analyst Carl…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DHI D.R. Horton
$94.92 /

+1.74 (+1.87%)

DHI D.R. Horton
$94.92 /

+1.74 (+1.87%)

04/21/21 Barclays
D.R. Horton price target raised to $108 from $95 at Barclays
04/15/21 Wells Fargo
D.R. Horton initiated with an Overweight at Wells Fargo
04/07/21 JPMorgan
JPMorgan lays out long and short homebuilding ideas into earnings
03/16/21 Wolfe Research
D.R. Horton initiated with Outperform, $94 target at Wolfe Research
DHI D.R. Horton
$94.92 /

+1.74 (+1.87%)

DHI D.R. Horton
$94.92 /

+1.74 (+1.87%)

DHI D.R. Horton
$94.92 /

+1.74 (+1.87%)

DHI D.R. Horton
$94.92 /

+1.74 (+1.87%)

Periodicals
TSMC approves capacity expansion for 28nm process at China fab, DigiTimes says » 06:13
04/23/21
04/23
06:13
04/23/21
06:13
TSM

TSMC

$115.27 /

-2.21 (-1.88%)

TSMC's board of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSM TSMC
$115.27 /

-2.21 (-1.88%)

TSM TSMC
$115.27 /

-2.21 (-1.88%)

04/21/21 Needham
Advanced Energy price target raised to $135 from $128 at Needham
04/21/21 Needham
Axcelis price target raised to $47 from $44 at Needham
04/21/21 Needham
Ichor Holdings price target raised to $64 from $46 at Needham
04/21/21 Needham
Nova Measuring price target raised to $100 from $87 at Needham
TSM TSMC
$115.27 /

-2.21 (-1.88%)

TSM TSMC
$115.27 /

-2.21 (-1.88%)

TSM TSMC
$115.27 /

-2.21 (-1.88%)

TSM TSMC
$115.27 /

-2.21 (-1.88%)

Downgrade
Pioneer Natural downgraded to Peer Perform from Outperform at Wolfe Research » 06:12
04/23/21
04/23
06:12
04/23/21
06:12
PXD

Pioneer Natural

$146.29 /

-0.775 (-0.53%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PXD Pioneer Natural
$146.29 /

-0.775 (-0.53%)

PXD Pioneer Natural
$146.29 /

-0.775 (-0.53%)

04/19/21 Truist
Pioneer Natural price target raised to $190 from $175 at Truist
04/15/21
Fly Intel: Top five analyst downgrades
04/15/21 Scotiabank
Scotiabank downgrades Pioneer Natural to Sector Perform amid sector shake-up
04/15/21 Scotiabank
Pioneer Natural downgraded to Sector Perform from Outperform at Scotiabank
PXD Pioneer Natural
$146.29 /

-0.775 (-0.53%)

PXD Pioneer Natural
$146.29 /

-0.775 (-0.53%)

PXD Pioneer Natural
$146.29 /

-0.775 (-0.53%)

PXD Pioneer Natural
$146.29 /

-0.775 (-0.53%)

Upgrade
Ovintiv upgraded to Outperform from Peer Perform at Wolfe Research » 06:11
04/23/21
04/23
06:11
04/23/21
06:11
OVV

Ovintiv

$21.96 /

-0.16 (-0.72%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OVV Ovintiv
$21.96 /

-0.16 (-0.72%)

OVV Ovintiv
$21.96 /

-0.16 (-0.72%)

03/30/21 Morgan Stanley
Ovintiv upgraded to Overweight upon assumption at Morgan Stanley
03/30/21 Morgan Stanley
Ovintiv upgraded to Overweight from Equal Weight at Morgan Stanley
03/29/21 Goldman Sachs
Ovintiv upgraded to Buy from Neutral at Goldman Sachs
03/24/21 Tudor Pickering
Ovintiv upgraded to Buy from Accumulate at Tudor Pickering
OVV Ovintiv
$21.96 /

-0.16 (-0.72%)

OVV Ovintiv
$21.96 /

-0.16 (-0.72%)

OVV Ovintiv
$21.96 /

-0.16 (-0.72%)

Periodicals
Amazon executives 'leaving in droves,' Business Insider reports » 06:11
04/23/21
04/23
06:11
04/23/21
06:11
AMZN

Amazon.com

$3,307.70 /

-54.17 (-1.61%)

Amazon's senior…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,307.70 /

-54.17 (-1.61%)

AMZN Amazon.com
$3,307.70 /

-54.17 (-1.61%)

04/22/21 Credit Suisse
Clean Energy bears missing elements of Amazon deal, says Credit Suisse
04/22/21 JPMorgan
Amazon is JPMorgan's favorite 'FANG' name into Q1 earnings
04/22/21 Morgan Stanley
Dish price target raised to $45 from $38 at Morgan Stanley
04/21/21 Oppenheimer
Amazon.com price target raised to $4,200 from $4,100 at Oppenheimer
AMZN Amazon.com
$3,307.70 /

-54.17 (-1.61%)

AMZN Amazon.com
$3,307.70 /

-54.17 (-1.61%)

AMZN Amazon.com
$3,307.70 /

-54.17 (-1.61%)

AMZN Amazon.com
$3,307.70 /

-54.17 (-1.61%)

Periodicals
Johnson & Johnson COVID-19 vaccine pause to be reviewed, WSJ reports » 06:10
04/23/21
04/23
06:10
04/23/21
06:10
JNJ

Johnson & Johnson

$165.16 /

-1.45 (-0.87%)

The Advisory Committee on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.16 /

-1.45 (-0.87%)

JNJ Johnson & Johnson
$165.16 /

-1.45 (-0.87%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
JNJ Johnson & Johnson
$165.16 /

-1.45 (-0.87%)

JNJ Johnson & Johnson
$165.16 /

-1.45 (-0.87%)

JNJ Johnson & Johnson
$165.16 /

-1.45 (-0.87%)

JNJ Johnson & Johnson
$165.16 /

-1.45 (-0.87%)

Upgrade
Marathon Oil upgraded to Outperform from Peer Perform at Wolfe Research » 06:10
04/23/21
04/23
06:10
04/23/21
06:10
MRO

Marathon Oil

$10.32 /

-0.12 (-1.15%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRO Marathon Oil
$10.32 /

-0.12 (-1.15%)

MRO Marathon Oil
$10.32 /

-0.12 (-1.15%)

04/13/21 Barclays
Marathon Oil price target raised to $13 from $9 at Barclays
03/23/21 Goldman Sachs
Marathon Oil assumed with a Sell at Goldman Sachs
03/23/21 Citi
Marathon Oil price target raised to $12 from $9 at Citi
01/14/21 Barclays
Marathon Oil upgraded to Overweight with $9 target at Barclays
MRO Marathon Oil
$10.32 /

-0.12 (-1.15%)

MRO Marathon Oil
$10.32 /

-0.12 (-1.15%)

MRO Marathon Oil
$10.32 /

-0.12 (-1.15%)

MRO Marathon Oil
$10.32 /

-0.12 (-1.15%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.